BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26576483)

  • 1. Enhanced expression of c-myc in hepatocytes promotes initiation and progression of alcoholic liver disease.
    Nevzorova YA; Cubero FJ; Hu W; Hao F; Haas U; Ramadori P; Gassler N; Hoss M; Strnad P; Zimmermann HW; Tacke F; Trautwein C; Liedtke C
    J Hepatol; 2016 Mar; 64(3):628-40. PubMed ID: 26576483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of c-myc in hepatocytes promotes activation of hepatic stellate cells and facilitates the onset of liver fibrosis.
    Nevzorova YA; Hu W; Cubero FJ; Haas U; Freimuth J; Tacke F; Trautwein C; Liedtke C
    Biochim Biophys Acta; 2013 Oct; 1832(10):1765-75. PubMed ID: 23770341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide synthase 6 (CerS6) is upregulated in alcohol-associated liver disease and exhibits sex-based differences in the regulation of energy homeostasis and lipid droplet accumulation.
    Jeon S; Scorletti E; Dempsey J; Buyco D; Lin C; Saiman Y; Bayen S; Harkin J; Martin J; Hooks R; Ogretmen B; Argemi J; Melo L; Bataller R; Carr RM
    Mol Metab; 2023 Dec; 78():101804. PubMed ID: 37714377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice.
    Hao F; Cubero FJ; Ramadori P; Liao L; Haas U; Lambertz D; Sonntag R; Bangen JM; Gassler N; Hoss M; Streetz KL; Reissing J; Zimmermann HW; Trautwein C; Liedtke C; Nevzorova YA
    Cell Death Dis; 2017 Oct; 8(10):e3152. PubMed ID: 29072704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocyte proliferation is the possible mechanism for the transient decrease in liver injury during steatosis stage of alcoholic liver disease.
    Apte UM; McRee R; Ramaiah SK
    Toxicol Pathol; 2004; 32(5):567-76. PubMed ID: 15603541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of Cyclin E1 in hepatocytes aggravates ethanol-induced liver injury and hepatic steatosis in experimental murine model of acute and chronic alcohol-associated liver disease.
    Ramadori P; Woitok MM; Estévez-Vázquez O; Benedé-Ubieto R; Leal-Lassalle H; Lamas-Paz A; Guo F; Fabre J; Otto J; Verwaayen A; Reissing J; Bruns T; Erschfeld S; Haas U; Paffen D; Nelson LJ; Vaquero J; Bañares R; Trautwein C; Cubero FJ; Liedtke C; Nevzorova YA
    Biochim Biophys Acta Mol Basis Dis; 2023 Apr; 1869(4):166646. PubMed ID: 36736843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential relationship between hepatobiliary osteopontin and peroxisome proliferator-activated receptor alpha expression following ethanol-associated hepatic injury in vivo and in vitro.
    Lee JH; Banerjee A; Ueno Y; Ramaiah SK
    Toxicol Sci; 2008 Nov; 106(1):290-9. PubMed ID: 18703563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential contributions of the tobacco nicotine-derived nitrosamine ketone (NNK) in the pathogenesis of steatohepatitis in a chronic plus binge rat model of alcoholic liver disease.
    Zabala V; Tong M; Yu R; Ramirez T; Yalcin EB; Balbo S; Silbermann E; Deochand C; Nunez K; Hecht S; de la Monte SM
    Alcohol Alcohol; 2015 Mar; 50(2):118-31. PubMed ID: 25618784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53/p66Shc-mediated signaling contributes to the progression of non-alcoholic steatohepatitis in humans and mice.
    Tomita K; Teratani T; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Nishiyama K; Mataki N; Irie R; Minamino T; Okada Y; Kurihara C; Ebinuma H; Saito H; Shimizu I; Yoshida Y; Hokari R; Sugiyama K; Hatsuse K; Yamamoto J; Kanai T; Miura S; Hibi T
    J Hepatol; 2012 Oct; 57(4):837-43. PubMed ID: 22641095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA 122, Regulated by GRLH2, Protects Livers of Mice and Patients From Ethanol-Induced Liver Disease.
    Satishchandran A; Ambade A; Rao S; Hsueh YC; Iracheta-Vellve A; Tornai D; Lowe P; Gyongyosi B; Li J; Catalano D; Zhong L; Kodys K; Xie J; Bala S; Gao G; Szabo G
    Gastroenterology; 2018 Jan; 154(1):238-252.e7. PubMed ID: 28987423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of farnesoid X receptor attenuates hepatic injury in a murine model of alcoholic liver disease.
    Wu W; Zhu B; Peng X; Zhou M; Jia D; Gu J
    Biochem Biophys Res Commun; 2014 Jan; 443(1):68-73. PubMed ID: 24269813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of hedgehog-responsive progenitors parallels alcoholic liver disease severity in mice and humans.
    Jung Y; Brown KD; Witek RP; Omenetti A; Yang L; Vandongen M; Milton RJ; Hines IN; Rippe RA; Spahr L; Rubbia-Brandt L; Diehl AM
    Gastroenterology; 2008 May; 134(5):1532-43. PubMed ID: 18471524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy.
    You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X
    J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myeloid-MyD88 Contributes to Ethanol-Induced Liver Injury in Mice Linking Hepatocellular Death to Inflammation.
    Zhou H; Yu M; Roychowdhury S; Sanz-Garcia C; Pollard KA; McMullen MR; Liu X; Li X; Nagy LE
    Alcohol Clin Exp Res; 2017 Apr; 41(4):719-726. PubMed ID: 28165624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization.
    Park JK; Shao M; Kim MY; Baik SK; Cho MY; Utsumi T; Satoh A; Ouyang X; Chung C; Iwakiri Y
    Hepatology; 2017 May; 65(5):1720-1734. PubMed ID: 28090670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A voluntary oral ethanol-feeding rat model associated with necroinflammatory liver injury.
    Tipoe GL; Liong EC; Casey CA; Donohue TM; Eagon PK; So H; Leung TM; Fogt F; Nanji AA
    Alcohol Clin Exp Res; 2008 Apr; 32(4):669-82. PubMed ID: 18341647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatic BMAL1/AKT/lipogenesis axis protects against alcoholic liver disease in mice via promoting PPARα pathway.
    Zhang D; Tong X; Nelson BB; Jin E; Sit J; Charney N; Yang M; Omary MB; Yin L
    Hepatology; 2018 Sep; 68(3):883-896. PubMed ID: 29534306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic Profiling of Liver and Plasma in Chronic Ethanol Feeding Model of Hepatic Alcohol Dehydrogenase-Deficient Deer Mice.
    Bhopale KK; Amer SM; Kaphalia L; Soman KV; Wiktorowicz JE; Shakeel Ansari GA; Kaphalia BS
    Alcohol Clin Exp Res; 2017 Oct; 41(10):1675-1685. PubMed ID: 28792616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-32γ attenuates ethanol-induced liver injury by the inhibition of cytochrome P450 2E1 expression and inflammatory responses.
    Lee DH; Kim DH; Hwang CJ; Song S; Han SB; Kim Y; Yoo HS; Jung YS; Kim SH; Yoon DY; Hong JT
    Clin Sci (Lond); 2015 May; 128(10):695-706. PubMed ID: 25583360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dihydroartemisinin inhibits ER stress-mediated mitochondrial pathway to attenuate hepatocyte lipoapoptosis via blocking the activation of the PI3K/Akt pathway.
    Chen X; Bian M; Zhang C; Kai J; Yao Z; Jin H; Lu C; Shao J; Chen A; Zhang F; Zheng S
    Biomed Pharmacother; 2018 Jan; 97():975-984. PubMed ID: 29136776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.